- Home
- / Legend Biotech
Legend Biotech
Revenue
$89.8 M
FY, 2021
Market Capitalization
$8.3 B
2023-01-19
Legend Biotech Summary
Company summary
- Overview
- Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications. Its lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma.
- Type
- Public
- Status
- Active
- Founded
- 2014
- HQ
- Somerset, NJ, US | view all locations
- Cybersecurity rating
- ESG rating
Key people
Ying Huang, Chief Financial Officer
Meeta Chatterjee, Senior Vice President, Global Business Development
Tracy Luo, Vice President, Clinical Development
LocationsView all
5 locations detected
Somerset, NJ HQ
United States
2101 Cottontail Lane
Piscataway, NJ
United States
10 Knightsbridge Road
Ghent, Vlaams Gewest
Belgium
Technologiepark 122
Nanjing
China
No. 6 Building, Life Science TechTown, 568 Longmian Avenue
Dublin, County Dublin
Ireland
10A Ballymoss Road, Sandyford Business Park
Footer menu
Products
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension